Medvi had an FDA warning letter. Then it invited The New York Times in

I saw the Medvi story blow up this weekend and had a moment. $1.8 billion in projected revenue. Two employees. AI doing everything else.

For about ten minutes, I thought I was in the wrong business. Then I kept reading.

FDA warning letter, two months before The New York Times piece dropped. 800+ fake doctor accounts on Facebook. A class-action filed last month. A founder who sat down at Soho House to talk about $3 million a day while the regulatory clock was already running.

The New York Times didn't create Medvi's crisis. It handed its founder CEO a megaphone.

If you're the General Counsel, Chief Communications Officer, or AI equivalent who greenlit that interview, here's what got missed: the viral moment isn't the problem. It's the exposure amplifier. Every claim in the story now has a shadow version sitting one search result away. The revenue. The efficiency. The Sam Altman co-sign. All of it.

This is a pattern. The bigger the launch, the harder the landing when the underlying facts and posture are wrong.

You don't fix that during an interview with the New York Times. You fix it before you pitch the story. Or before you answer any reporter's call.

The pre-crisis window is where governance either holds or fails. An FDA warning letter that existed two months before the Times interview wasn't a secret. A competent crisis posture would have resolved it, or at minimum built a containment response before inviting national media in. Instead, the story ran. And now every element of the viral narrative has a shadow version ready to surface.

Medvi may be the first AI-native billion-dollar company. It might also be one of the first clean case studies of what happens when you scale the business faster than governance can keep up.

I'm going to run this one through CrisisCommand as more details surface. It's worth documenting in real time. The decisions being made in the next few days, and the ones that weren't made in the months prior, are exactly the architecture this platform is built to stress-test.

FYI, I'm not in the wrong business.